These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12760438)

  • 1. Do epileptic children treated with valproate have a risk of excessive weight gain?
    Bosnak M; Dikici B; Haspolat K; Dagli A; Dikici S
    J Child Neurol; 2003 Apr; 18(4):306; author reply 306. PubMed ID: 12760438
    [No Abstract]   [Full Text] [Related]  

  • 2. Does ghrelin really increase in epileptic children treated with valproate?
    Aydin S; Dag E
    J Child Neurol; 2008 Sep; 23(9):1084. PubMed ID: 18827274
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight gain in children treated with valproate.
    Sharpe C; Wolfson T; Trauner DA
    J Child Neurol; 2009 Mar; 24(3):338-41. PubMed ID: 19258293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of excessive weight gain in epileptic children treated with valproate.
    Novak GP; Maytal J; Alshansky A; Eviatar L; Sy-Kho R; Siddique Q
    J Child Neurol; 1999 Aug; 14(8):490-5. PubMed ID: 10456757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications.
    Verrotti A; D'Egidio C; Mohn A; Coppola G; Chiarelli F
    Obes Rev; 2011 May; 12(5):e32-43. PubMed ID: 20880119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and plasma concentrations of alpha-tocopherol and beta-carotene in epileptic girls treated with valproate.
    Verrotti A; Greco R; Latini G; De Simone M; Chiarelli F
    Neuroendocrinology; 2004 Mar; 79(3):157-62. PubMed ID: 15103229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of valproic acid-associated weight gain in prepubertal children.
    Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
    Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial.
    Biton V; Levisohn P; Hoyler S; Vuong A; Hammer AE
    J Child Neurol; 2003 Feb; 18(2):133-9. PubMed ID: 12693782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precocious puberty in an epileptic child treated with valproate.
    Zaiem A; Aouinti I; Lakhoua G; Kastalli S; Daghfous R; Lakhal M; El Aïdli S
    Therapie; 2012; 67(6):537-8. PubMed ID: 23249581
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum insulin and leptin levels and valproate-associated obesity.
    Verrotti A; di Corcia G; Salladini C; Trotta D; Morgese G; Chiarelli F
    Epilepsia; 2003 Dec; 44(12):1606. PubMed ID: 14636339
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy.
    Kanemura H; Sano F; Maeda Y; Sugita K; Aihara M
    Seizure; 2012 Sep; 21(7):496-500. PubMed ID: 22694920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.
    Aydin K; Serdaroglu A; Okuyaz C; Bideci A; Gucuyener K
    J Child Neurol; 2005 Oct; 20(10):848-51. PubMed ID: 16417885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change in monozygotic twins treated with valproate.
    Klein KM; Hamer HM; Reis J; Schmidtke J; Oertel WH; Theisen FM; Hebebrand J; Rosenow F
    Obes Res; 2005 Aug; 13(8):1330-4. PubMed ID: 16129714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight gain and insulin resistance in children treated with valproate: the influence of time.
    Masuccio F; Verrotti A; Chiavaroli V; de Giorgis T; Giannini C; Chiarelli F; Mohn A
    J Child Neurol; 2010 Aug; 25(8):941-7. PubMed ID: 20207607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced insulin resistance and obesity in children.
    Verrotti A; la Torre R; Trotta D; Mohn A; Chiarelli F
    Horm Res; 2009; 71(3):125-31. PubMed ID: 19188736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight change, genetics and antiepileptic drugs.
    Chukwu J; Delanty N; Webb D; Cavalleri GL
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):43-51. PubMed ID: 24308788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
    Prodam F; Bellone S; Casara G; De Rienzo F; Grassino EC; Bonsignori I; Demarchi I; Rapa A; Radetti G; Bona G
    Epilepsia; 2010 Feb; 51(2):312-5. PubMed ID: 19780793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid-associated weight gain in older children and teens with epilepsy.
    Wirrell EC
    Pediatr Neurol; 2003 Feb; 28(2):126-9. PubMed ID: 12699863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight gain in children on oxcarbazepine monotherapy.
    Garoufi A; Vartzelis G; Tsentidis C; Attilakos A; Koemtzidou E; Kossiva L; Katsarou E; Soldatou A
    Epilepsy Res; 2016 May; 122():110-3. PubMed ID: 27010568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and endocrine effects of valproic acid chronic treatment.
    Belcastro V; D'Egidio C; Striano P; Verrotti A
    Epilepsy Res; 2013 Nov; 107(1-2):1-8. PubMed ID: 24076030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.